|
Intensive
Chemical Dependency Evaluation
A Full,
Professional Addiction Assessment
ARRNO’s
Intensive Chemical Dependency
Evaluation (ICDE) is a five-day
evaluation process designed to
provide an individual with a
structured, intensive,
criteria-based evaluation for the
disease of chemical dependency. A
formal evaluation report is then
sent to any relevant licensing
board, including those for nurses,
pharmacists and physicians.
The evaluation
determines:
-
If
the patient demonstrates the
signs and symptoms of abuse or
dependency.
-
If
there is the presence of a
co-morbid psychiatric illness.
-
The
extent to which a patient is
living outside of his or her
value systems.
-
If
there are any emotional or
trauma issues that may hinder
treatment and/or recovery.
-
If
there are any medical conditions
that would affect the course of
treatment.
-
The
level of treatment that would be
most beneficial for the patient.
Program Content:
The patient lives in Addiction
Recovery Resources’ recovering
community and receives therapeutic
interventions that will allow the
Medical Director to determine the
nature of the disease and the
correct treatment recommendation.
Interventions:
-
Thorough health history and
systems review, including
complete lab screening and urine
drug screen.
-
Psychiatric Evaluation and
diagnosis by a qualified
physician.
-
Substance Abuse Evaluation by a
Master’s level psychotherapist,
including Addiction Severity
Index (ASI) and Substance Abuse
Subtle Screening Inventory (SASSI).
-
Direct observation of the
patient in a treatment
environment.
-
Individual session with a
Master’s level psychotherapist
to identify possibility of
significant trauma issues that
may have a bearing on treatment.
ICDE Lite:
In the event that the residential
component is not required, a
determination of patient needs will
be assessed using both testing
instruments and impressions in the
interview process.
Contact:
Lisa Carroll,
Intake Coordinator
Toll
free: 1-866-399-HOPE
Telephone:
504-780-2766, ext. 113
Fax:
504-780-9699
|
